Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy.

Jacob R, Strati P, Palaskas N, Lopez-Mattei JC, Marmagkiolis K, Buja LM, Deswal A, Iliescu C.

Open source

DOI
10.1016/j.jaccas.2020.07.033
Published
2020-09-30
Container
JACC Case Rep
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccas.2020.07.033,
  title = {Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy.},
  author = {Jacob R and  Strati P and  Palaskas N and  Lopez-Mattei JC and  Marmagkiolis K and  Buja LM and  Deswal A and  Iliescu C.},
  year = {2020},
  journal = {JACC Case Rep},
  doi = {10.1016/j.jaccas.2020.07.033},
  url = {https://doi.org/10.1016/j.jaccas.2020.07.033}
}

RIS

TY  - JOUR
TI  - Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy.
AU  - Jacob R
AU  -  Strati P
AU  -  Palaskas N
AU  -  Lopez-Mattei JC
AU  -  Marmagkiolis K
AU  -  Buja LM
AU  -  Deswal A
AU  -  Iliescu C.
PY  - 2020
JO  - JACC Case Rep
DO  - 10.1016/j.jaccas.2020.07.033
UR  - https://doi.org/10.1016/j.jaccas.2020.07.033
ER  - 

APA

R, J., P, S., N, P., JC, L., K, M., LM, B., A, D., & C., I. (2020). Lenalidomide-Induced Myocarditis, Rare But Possibly Fatal Toxicity of a Commonly Used Immunotherapy.. JACC Case Rep. https://doi.org/10.1016/j.jaccas.2020.07.033

Source records